BCR::ABL1 Kinase Domain Variant (Mutation) Status

The scheme BCR::ABL1 Kinase Domain Variant (Mutation) Status is provided by UK NEQAS and is completely outside the responsibility of the SKML.

The SKML only facilitates its own participants to subscribe for this scheme.
Only the (re) registration and invoicing of this scheme will be arranged by SKML.
You don?t have to respond to (re) registration emails from these external organizations.

Also see https://ukneqas.org.uk/programmes/result/?programme=bcr%3A%3Aabl1-kinase-domain-variant-%28mutation%29-status

Frequency

3 rounds of 2 samples

Number of participants

7

Price

Participation
€ 472.50
Additional sample set
€ 126.00

Details

Questions about this scheme?

Use the form below to send us a message.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.